MY172426A - Ion exchange membrane chromatography - Google Patents

Ion exchange membrane chromatography

Info

Publication number
MY172426A
MY172426A MYPI2014701665A MYPI2014701665A MY172426A MY 172426 A MY172426 A MY 172426A MY PI2014701665 A MYPI2014701665 A MY PI2014701665A MY PI2014701665 A MYPI2014701665 A MY PI2014701665A MY 172426 A MY172426 A MY 172426A
Authority
MY
Malaysia
Prior art keywords
polypeptide
membrane
ion exchange
effluent
interest
Prior art date
Application number
MYPI2014701665A
Other languages
English (en)
Inventor
Jerome Joseph Bill Jr
Arick Michael Brown
Christopher John Dowd
Brooke Ellen Thayer
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47430154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY172426(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MY172426A publication Critical patent/MY172426A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/165Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
MYPI2014701665A 2011-12-22 2012-12-18 Ion exchange membrane chromatography MY172426A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161579285P 2011-12-22 2011-12-22

Publications (1)

Publication Number Publication Date
MY172426A true MY172426A (en) 2019-11-25

Family

ID=47430154

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014701665A MY172426A (en) 2011-12-22 2012-12-18 Ion exchange membrane chromatography

Country Status (21)

Country Link
US (3) US10364268B2 (cg-RX-API-DMAC7.html)
EP (2) EP2794635B8 (cg-RX-API-DMAC7.html)
JP (5) JP6605202B2 (cg-RX-API-DMAC7.html)
KR (3) KR20200008022A (cg-RX-API-DMAC7.html)
CN (2) CN104125963B (cg-RX-API-DMAC7.html)
AR (1) AR089362A1 (cg-RX-API-DMAC7.html)
AU (3) AU2012355356B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014015101A8 (cg-RX-API-DMAC7.html)
CA (1) CA2859376C (cg-RX-API-DMAC7.html)
ES (1) ES2697676T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20181846T1 (cg-RX-API-DMAC7.html)
IL (2) IL267585B (cg-RX-API-DMAC7.html)
MX (2) MX360453B (cg-RX-API-DMAC7.html)
MY (1) MY172426A (cg-RX-API-DMAC7.html)
PL (1) PL2794635T3 (cg-RX-API-DMAC7.html)
RU (1) RU2648999C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201403437TA (cg-RX-API-DMAC7.html)
SI (1) SI2794635T1 (cg-RX-API-DMAC7.html)
TR (1) TR201815709T4 (cg-RX-API-DMAC7.html)
WO (1) WO2013096322A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA201404593B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2648999C2 (ru) * 2011-12-22 2018-03-29 Дженентек, Инк. Способы повышения эффективности этапов очистки белка, находящихся ниже по потоку, с использованием мембранной ионообменной хроматографии
WO2015088677A1 (en) 2013-12-12 2015-06-18 Emd Millipore Corporation Protein separations using an acrylamide containing filter
CN106029682B (zh) * 2013-12-27 2021-04-13 中外制药株式会社 等电点低的抗体的纯化方法
CN104693303B (zh) * 2015-02-28 2018-03-13 苏州金盟生物技术有限公司 一种蛋白制品中的核酸去除方法
WO2017027861A1 (en) 2015-08-13 2017-02-16 Amgen Inc. Charged depth filtration of antigen-binding proteins
GB201711481D0 (en) 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
US10792618B2 (en) 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
KR102140531B1 (ko) * 2018-08-07 2020-08-04 (주)휴온스 Gly-Tβ4의 제조방법
GB201815405D0 (en) * 2018-09-21 2018-11-07 Fujifilm Mfg Europe Bv Membranes suitable for detecting, filtering and/or purifying biomolecules
US12306152B2 (en) 2018-12-21 2025-05-20 Solventum Intellectual Properties Company Method for testing a chromatography device used for ion exchange
AR119264A1 (es) * 2019-06-05 2021-12-09 Genentech Inc Método para reutilización de cromatografía
MX2022009134A (es) * 2020-01-24 2022-10-21 Alkermes Pharma Ireland Ltd Metodos de purificacion.
US11416468B2 (en) * 2020-07-21 2022-08-16 International Business Machines Corporation Active-active system index management
CN116371011B (zh) * 2023-05-26 2023-08-18 湖南杰萃生物技术有限公司 一种从桑叶中提取黄酮和生物碱的方法
CN117866038B (zh) * 2024-03-11 2024-05-28 北京百力格生物科技有限公司 纯化含有宿主核酸的带亲和标签的酸性蛋白的方法

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (cg-RX-API-DMAC7.html)
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
JPS6150925A (ja) * 1984-08-17 1986-03-13 Toray Ind Inc 抗原または抗体の精製方法
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
ATE121418T1 (de) * 1987-10-23 1995-05-15 Schering Corp Verfahren zur proteinreinigung.
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
DE68919361T2 (de) 1988-06-21 1995-05-24 Genentech Inc Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
JP2844346B2 (ja) * 1989-05-31 1999-01-06 昭 梶 新規ペプチドならびに新規dna
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
AU2498192A (en) 1991-08-14 1993-03-16 Genentech Inc. Immunoglobulin variants for specific fc epsilon receptors
DK1136556T3 (da) 1991-11-25 2005-10-03 Enzon Inc Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner
DE69333807T2 (de) 1992-02-06 2006-02-02 Chiron Corp., Emeryville Marker für krebs und biosynthetisches bindeprotein dafür
CA2140933A1 (en) 1992-08-21 1994-02-22 Paula M. Jardieu Method for treating an lfa-1 mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
JP4057049B2 (ja) 1993-09-21 2008-03-05 ヘモソル インコーポレーテッド 置換クロマトグラフィー法および精製ヘモグロビン産物
JP3507852B2 (ja) 1993-12-10 2004-03-15 ジェネンテク,インコーポレイテッド アレルギー診断法および抗アレルギー性治療剤のスクリーニング法
JP3825798B2 (ja) 1994-01-18 2006-09-27 ジェネンテク,インコーポレイテッド IgEアンタゴニストを用いる寄生虫感染症の治療法
US5707622A (en) 1994-03-03 1998-01-13 Genentech, Inc. Methods for treating ulcerative colitis
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CA2222231A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
WO1997026912A2 (en) 1996-01-23 1997-07-31 Genentech, Inc. Anti-cd18 antibodies for use against stroke
US6592905B1 (en) * 1996-01-31 2003-07-15 Massey University Production of an immunoglobulin enriched fraction from whey protein solutions
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
DE122004000047I2 (de) 1996-11-27 2006-06-14 Genentech Inc Humanisierte anti-koerper gegen CD11A
SI1325932T1 (cg-RX-API-DMAC7.html) 1997-04-07 2005-08-31 Genentech Inc
DK1860187T3 (da) 1997-05-15 2011-10-31 Genentech Inc Apo-2-receptor
US6054293A (en) 1997-07-08 2000-04-25 The Regents Of The University Of California Semaphorin receptors
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
BRPI0012198B8 (pt) 1999-06-25 2021-05-25 Genentech Inc anticorpos humanizados, composição e imunoconjugado
ES2309012T3 (es) 1999-10-29 2008-12-16 Genentech, Inc. Composiciones del anticuerpo anti-psca y a sus procedimientos contra celulas cancerigenas que expresen psca.
WO2002006456A1 (en) 2000-07-13 2002-01-24 Invitrogen Corporation Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
WO2003025156A2 (en) 2001-09-18 2003-03-27 Affinium Pharmaceuticals, Inc. Methods and apparatuses for purification
WO2003033656A2 (en) 2001-10-16 2003-04-24 Exelixis, Inc. MSREBPs AS MODIFIERS OF THE SREBP PATHWAY AND METHODS OF USE
WO2003033658A2 (en) 2001-10-17 2003-04-24 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
CN100522999C (zh) 2002-02-14 2009-08-05 免疫医疗公司 抗cd20抗体及其融合蛋白和使用方法
PT1558648E (pt) 2002-10-17 2012-04-23 Genmab As Anticorpos monoclonais humanos contra cd20
WO2004056312A2 (en) 2002-12-16 2004-07-08 Genentech, Inc. Immunoglobulin variants and uses thereof
CN1206240C (zh) * 2003-04-07 2005-06-15 中国科学院生态环境研究中心 高效离子交换膜色谱纯化卵黄蛋白原技术
JP5416338B2 (ja) 2003-05-09 2014-02-12 デューク ユニバーシティ Cd20特異的抗体およびその使用方法
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
WO2005014618A2 (en) 2003-08-08 2005-02-17 Immunomedics, Inc. Bispecific antibodies for inducing apoptosis of tumor and diseased cells
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
US20080274501A1 (en) * 2007-05-02 2008-11-06 Chenming Zhang Method of purifying acidic proteins expressed in plants
US9433922B2 (en) 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
KR101163307B1 (ko) * 2007-10-26 2012-07-05 아사히 가세이 케미칼즈 가부시키가이샤 단백질의 정제 방법
RU2498991C2 (ru) 2007-10-30 2013-11-20 Дженентек, Инк. Очистка антител с помощью катионообменной хроматографии
WO2009135656A1 (en) * 2008-05-06 2009-11-12 Lonza Biologics Plc. A method for the purification of antibodies using displacement chromatography
HUE047316T2 (hu) * 2008-08-14 2020-04-28 Genentech Inc Eljárások szennyezés eltávolítására indigén fehérjekiszorításos ioncserés membrán kromatográfia alkalmazásával
GB0816242D0 (en) 2008-09-05 2008-10-15 Immunobiology Ltd Method of purifying protien complexes
SI2462158T1 (en) 2009-08-06 2018-04-30 F. Hoffmann-La Roche Ag Method to improve virus removal in protein purification
CN102686738A (zh) 2009-09-01 2012-09-19 弗·哈夫曼-拉罗切有限公司 通过改进的a蛋白洗脱增强的蛋白质纯化
RU2624027C2 (ru) * 2010-04-23 2017-06-30 Дженентек, Инк. Получение гетеромультимерных белков
EP3299380B1 (en) 2010-05-25 2024-08-28 F. Hoffmann-La Roche AG Methods of purifying polypeptides
JP2014531604A (ja) * 2011-10-03 2014-11-27 サッチェム,インコーポレイテッド 疎水性置換クロマトグラフィーのためのアニオン性置換剤分子
RU2648999C2 (ru) 2011-12-22 2018-03-29 Дженентек, Инк. Способы повышения эффективности этапов очистки белка, находящихся ниже по потоку, с использованием мембранной ионообменной хроматографии
WO2015198451A1 (ja) 2014-06-26 2015-12-30 楽天株式会社 情報処理装置、情報処理方法及び情報処理プログラム

Also Published As

Publication number Publication date
JP2015503524A (ja) 2015-02-02
AR089362A1 (es) 2014-08-20
US20200102346A1 (en) 2020-04-02
EP3492486A1 (en) 2019-06-05
WO2013096322A9 (en) 2013-08-22
JP7402011B2 (ja) 2023-12-20
EP2794635A1 (en) 2014-10-29
AU2012355356B2 (en) 2017-10-12
US11945837B2 (en) 2024-04-02
JP6605202B2 (ja) 2019-11-13
NZ626949A (en) 2016-11-25
AU2018200194A1 (en) 2018-02-01
IL267585B (en) 2022-09-01
JP2022101557A (ja) 2022-07-06
IL267585A (en) 2019-08-29
WO2013096322A8 (en) 2014-02-27
PL2794635T3 (pl) 2019-02-28
RU2014130017A (ru) 2016-02-10
AU2012355356A1 (en) 2014-07-10
IL233158A0 (en) 2014-07-31
BR112014015101A8 (pt) 2021-06-08
CN108892706A (zh) 2018-11-27
US20140348845A1 (en) 2014-11-27
RU2648999C2 (ru) 2018-03-29
BR112014015101A2 (pt) 2017-06-13
ZA201404593B (en) 2022-12-21
ZA201903994B (en) 2023-12-20
HRP20181846T1 (hr) 2018-12-28
AU2018200194B2 (en) 2019-11-14
AU2020201070A1 (en) 2020-03-05
JP7359807B2 (ja) 2023-10-11
SI2794635T1 (sl) 2018-12-31
MX2014007622A (es) 2014-09-22
MX360453B (es) 2018-11-01
TR201815709T4 (tr) 2018-11-21
CN104125963B (zh) 2018-08-17
CA2859376A1 (en) 2013-06-27
IL233158B (en) 2019-07-31
US10364268B2 (en) 2019-07-30
JP2018109024A (ja) 2018-07-12
CA2859376C (en) 2022-04-19
WO2013096322A1 (en) 2013-06-27
JP2020040952A (ja) 2020-03-19
EP2794635B1 (en) 2018-09-12
ES2697676T3 (es) 2019-01-25
US20240247027A1 (en) 2024-07-25
KR20140114834A (ko) 2014-09-29
EP2794635B8 (en) 2018-11-14
SG11201403437TA (en) 2014-07-30
KR20200008022A (ko) 2020-01-22
MX2018013356A (es) 2020-09-14
KR20210025692A (ko) 2021-03-09
JP2021169454A (ja) 2021-10-28
KR102067075B1 (ko) 2020-01-17
HK1203526A1 (en) 2015-10-30
CN104125963A (zh) 2014-10-29

Similar Documents

Publication Publication Date Title
ZA201903994B (en) Ion exchange membrane chromatography
CY1122221T1 (el) Μεθοδοι αφαιρεσης ρυπου χρησιμοποιωντας ιοντοανταλλακτικη μεμβρανικη χρωματογραφια μετατοπισης γηγενων πρωτεϊνων
EA201592192A1 (ru) Способ очистки моноклональных антител
PH12013501128A1 (en) Antibody purification by cation exchange chromatography
WO2011106750A3 (en) Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system
WO2017160360A3 (en) Scalable purification method for aav9
MX2012000841A (es) Optimizacion de la produccion de anticuerpos.
RU2014111820A (ru) Способы элиминации вируса
EP2522724A4 (en) POLYPEPTIDE MODIFYING METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS
AU2012231686A8 (en) Processes for recovering rare earth elements from aluminum-bearing materials
NZ603616A (en) Apparatus and process of purification of proteins
MX368161B (es) Metodo para purificar el virus de rabia.
SG10201804200WA (en) Protein separations using an acrylamide containing filter
MX395730B (es) Uso de lavados alcalinos durante la cromatografia para remover impurezas.
AU2014370873A1 (en) Method for purifying antibody having low isoelectric point
GB2443505B (en) Nucleic acid purification method
WO2010151632A8 (en) Protein purification by caprylic acid (octanoic acid ) precipitation
IN2012DN02869A (cg-RX-API-DMAC7.html)
EA201291224A1 (ru) Способ извлечения бетаина из мелассы
MX2014002204A (es) Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma.
WO2012108669A3 (ko) 우라닐 이온-특이적 dna 앱타머
WO2011130809A8 (en) Fractionation of ions from aqueous solutions
WO2018096272A3 (fr) Procédé de purification utilisant une résine de faible granulométrie
HK1213795A1 (zh) 使用疏水作用層析法進行蛋白質的提純
MX2013013224A (es) Procedimiento de purificacion de proteinas de bajo ph.